Overcoming challenges of immune checkpoint inhibitor-induced myocarditis diagnosis

Arch Cardiovasc Dis. 2023 Oct;116(10):429-432. doi: 10.1016/j.acvd.2023.07.002. Epub 2023 Aug 2.

¹ Department of Cardiology, North Hospital, Assistance publique-Hôpitaux de Marseille, Centre for CardioVascular and Nutrition Research (C2VN), Unit of Heart Failure and Valvular Heart Diseases, Aix-Marseille University, University Mediterranean Center of Cardio-Oncology,, Inserm 1263, Inrae 1260, Marseille, France. Electronic address: jennifer.cautela@ap-hm.fr.
² Department of Cardiology, North Hospital, Assistance publique-Hôpitaux de Marseille, Centre for CardioVascular and Nutrition Research (C2VN), Unit of Heart Failure and Valvular Heart Diseases, Aix-Marseille University, University Mediterranean Center of Cardio-Oncology,, Inserm 1263, Inrae 1260, Marseille, France.

No abstract available

Keywords: Cancer; Cardio-oncology; Diagnosis; Immunotherapy; Myocarditis.

Publication types